Endophenotypic Variations of Atopic Dermatitis by Age, Race, and Ethnicity
- 1 June 2020
- journal article
- review article
- Published by Elsevier in The Journal of Allergy and Clinical Immunology: In Practice
- Vol. 8 (6) , 1840-1852
Abstract
No abstract availableKeywords
Funding Information
- AbbVie
- Celgene
- Eli Lilly
- Janssen
- MedImmune
- AstraZeneca
- Novartis
- Pfizer
- Regeneron
- Vitae
- Glenmark
- Galderma
- Asana
- Innovaderm
- Dermira
This publication has 164 references indexed in Scilit:
- One Remarkable Molecule: FilaggrinJournal of Investigative Dermatology, 2012
- Genetic Variants in Interferon Regulatory Factor 2 (IRF2) Are Associated with Atopic Dermatitis and Eczema HerpeticumJournal of Investigative Dermatology, 2012
- Nonlesional atopic dermatitis skin is characterized by broad terminal differentiation defects and variable immune abnormalitiesJournal of Allergy and Clinical Immunology, 2011
- Eczema Prevalence in the United States: Data from the 2003 National Survey of Children's HealthJournal of Investigative Dermatology, 2011
- Genetic variants in thymic stromal lymphopoietin are associated with atopic dermatitis and eczema herpeticumJournal of Allergy and Clinical Immunology, 2010
- An update on the genetics of atopic dermatitis: Scratching the surface in 2009Journal of Allergy and Clinical Immunology, 2010
- IL-22–producing “T22” T cells account for upregulated IL-22 in atopic dermatitis despite reduced IL-17–producing TH17 T cellsJournal of Allergy and Clinical Immunology, 2009
- Cytokine-mediated regulation of antimicrobial proteinsNature Reviews Immunology, 2008
- Efficacy and safety of ustekinumab, a human interleukin-12/23 monoclonal antibody, in patients with psoriasis: 52-week results from a randomised, double-blind, placebo-controlled trial (PHOENIX 2)The Lancet, 2008
- Common loss-of-function variants of the epidermal barrier protein filaggrin are a major predisposing factor for atopic dermatitisNature Genetics, 2006